A Multicenter, Double-Blind, Placebo-Controlled Trial of the PDE9A Inhibitor, PF-04447943, in Alzheimer’s Disease

By  

Current Alzheimer Research, Vol. 11, Iss. 5, 2014-06 ,pp. : 413-421

Bentham Science Publishers

Access to resources Recommend Favorite

Randomized, Double-Blind, Placebo-Controlled International Clinical Trial of the AMPAKINE^® CX516 in Elderly Participants with Mild Cognitive Impairment

By Johnson S.A.   Simmon V.F.  

Journal of Molecular Neuroscience, Vol. 19, Iss. 1-2, 2002-10 ,pp. : 197-200

Humana Press, Inc

Access to resources Recommend Favorite

Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for ALS

By Beghi Ettore   Pupillo Elisabetta   Bonito Virginio   Buzzi Paolo   Caponnetto Claudia   Chiò Adriano   Corbo Massimo   Giannini Fabio   Inghilleri Maurizio   Bella Vincenzo La   Logroscino Giancarlo   Lorusso Lorenzo   Lunetta Christian   Mazzini Letizia   Messina Paolo   Mora Gabriele   Perini Michele   Quadrelli Maria Lidia   Silani Vincenzo   Simone Isabella L.   Tremolizzo Lucio  

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, Vol. 14, Iss. 5-6, 2013-09 ,pp. : 397-405

Informa Healthcare

Access to resources Recommend Favorite

Oral Zinc Sulphate Supplementation for Six Months in SCA2 Patients: A Randomized, Double-Blind, Placebo-Controlled Trial

By Velázquez-Pérez Luis  

Neurochemical Research, Vol. 36, Iss. 10, 2011-10 ,pp. : 1793-1800

Springer Publishing Company

Access to resources Recommend Favorite

Olanzapine in the Treatment of Developmental Stuttering: A Double-Blind, Placebo-Controlled Trial

By MAGUIRE GERALD   RILEY GLYNDON   FRANKLIN DAVID   MAGUIRE MICHAEL   NGUYEN CHARLES   BROJENI PEDRAM  

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 16, Iss. 2, 2004-01 ,pp. : 63-67

Informa Healthcare

Access to resources Recommend Favorite